{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:37:17Z","timestamp":1793090237271,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105613","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:25:44Z","timestamp":1790205944000},"page":"105613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The abscopal effect in cancer therapy: A scoping review"],"prefix":"10.1016","volume":"227","author":[{"given":"Antonio","family":"Ghidini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Roncari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bukovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mastrelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Petrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr. Probl. Cancer"},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105613_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0360-3016(77)90020-7","article-title":"Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas","volume":"2","author":"Antoniades","year":"1977","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105613_bib3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"issue":"28","key":"10.1016\/j.critrevonc.2026.105613_bib4","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1200\/JCO.2010.28.9793","article-title":"In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I\/II study","volume":"28","author":"Brody","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105613_bib5","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105613_bib6","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.170.12.6338","article-title":"Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy","volume":"170","author":"Chakraborty","year":"2003","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105613_bib7","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1158\/0008-5472.CAN-04-0073","article-title":"External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing","volume":"64","author":"Chakraborty","year":"2004","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105613_bib8","first-page":"6028","article-title":"Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer","volume":"59","author":"Chakravarty","year":"1999","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105613_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1046028","article-title":"A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab","volume":"4","author":"Chandra","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105613_bib10","first-page":"1760","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Chao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105613_bib11","article-title":"Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: challenges and future prospects","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib12","first-page":"5","article-title":"Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: a systematic review","volume":"9","author":"Chicas-Sett","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41416-024-02898-y","article-title":"The abscopal effects of sonodynamic therapy in cancer","volume":"132","author":"Collins","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105613_bib14","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.celrep.2019.04.098","article-title":"The genomic and immune landscapes of lethal metastatic breast cancer","volume":"27","author":"De Mattos-Arruda","year":"2019","journal-title":"Cell Rep."},{"issue":"1109","key":"10.1016\/j.critrevonc.2026.105613_bib15","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200042","article-title":"The abscopal effect 67 years later: from a side story to center stage","volume":"93","author":"Demaria","year":"2020","journal-title":"Br. J. Radiol."},{"issue":"2 Pt 1","key":"10.1016\/j.critrevonc.2026.105613_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105613_bib17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105613_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type i interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105613_bib20","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105613_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-17-0581","article-title":"Exosomes shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from irradiated cancer cells to DCs","volume":"6","author":"Diamond","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105613_bib22","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105613_bib23","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/1097-0142(19810415)47:8<2102::AID-CNCR2820470833>3.0.CO;2-K","article-title":"Spontaneous regression of metastases of renal cancer","volume":"47","author":"Fairlamb","year":"1981","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","article-title":"Exploring the emerging role of the microbiome in cancer immunotherapy","volume":"7","author":"Fessler","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105613_bib25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation therapy to convert the tumor into an in situ vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"740","key":"10.1016\/j.critrevonc.2026.105613_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2014.07.005","article-title":"Radiotherapy and immunogenic cell death","volume":"25","author":"Golden","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105613_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and GM-CSF to generate abscopal responses","volume":"16","author":"Golden","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib29","article-title":"Abscopal effects of radiotherapy","volume":"3","author":"Grimaldi","year":"2014","journal-title":"Oncoimmunology"},{"issue":"7668","key":"10.1016\/j.critrevonc.2026.105613_bib30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105613_bib31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijrobp.2016.07.005","article-title":"A prospective clinical trial combining radiation therapy with systemic immunotherapy","volume":"96","author":"Hiniker","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105613_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS8597","article-title":"Phase 3, randomized, placebo-controlled study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab in patients with unresected stage I or II non\u2013small cell lung cancer (NSCLC): KEYNOTE-867","volume":"40","author":"Jabbour","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"574","key":"10.1016\/j.critrevonc.2026.105613_bib33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1259\/0007-1285-48-574-863","article-title":"Possible abscopal effect in melanoma","volume":"48","author":"Kingsley","year":"1975","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s13691-013-0130-x","article-title":"Possible abscopal effect","volume":"3","author":"Kodama","year":"2014","journal-title":"Int. Cancer Conf. J."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105613_bib35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","article-title":"Ipilimumab vs placebo after radiotherapy","volume":"15","author":"Kwon","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib36","first-page":"438","article-title":"Blockade of CD73 potentiates radiotherapy antitumor immunity and abscopal effects via STING pathway","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.critrevonc.2026.105613_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib38","article-title":"Modern cancer therapy","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib39","article-title":"Modern cancer therapy: cryoablation meets immune checkpoint blockade","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105613_bib40","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol."},{"issue":"7668","key":"10.1016\/j.critrevonc.2026.105613_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105613_bib42","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/annonc\/mdy423","article-title":"Intratumoral immunotherapy (HIT-IT)","volume":"29","author":"Marabelle","year":"2018","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib43","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"CXCL16 release attracts T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-019-0588-y","article-title":"Radiosurgery + immunotherapy","volume":"7","author":"Minniti","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"305","key":"10.1016\/j.critrevonc.2026.105613_bib45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation","volume":"26","author":"Mole","year":"1953","journal-title":"Br. J. Radiol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105613_bib46","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(23)00479-5","article-title":"Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol."},{"issue":"10185","key":"10.1016\/j.critrevonc.2026.105613_bib47","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"SABR-COMET trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105613_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3857\/roj.2021.00115","article-title":"Abscopal effect in radio\/immunotherapy","volume":"39","author":"Pevzner","year":"2021","journal-title":"Radiat. Oncol. J."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105613_bib49","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1080\/21645515.2015.1049779","article-title":"In-situ tumor vaccination","volume":"11","author":"Pierce","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105613_bib50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates","volume":"366","author":"Postow","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105613_bib51","article-title":"Physical parameters and biological factors affect the abscopal effect of combining radiotherapy with immunotherapy: an update on preclinical works","volume":"12","author":"Ren","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.critrevonc.2026.105613_bib52","article-title":"Factors affecting abscopal effect","volume":"12","author":"Ren","year":"2025","journal-title":"Front. Public Health"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105613_bib53","first-page":"644","article-title":"Mechanisms. Trends Immunol","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/tcr-22-2354","article-title":"The abscopal effect and its implications for radiotherapy-immunotherapy combinations","volume":"12","author":"Rowell","year":"2023","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib55","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/tcr-22-2354","article-title":"Abscopal effect implications","volume":"12","author":"Rowell","year":"2023","journal-title":"Transl. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105613_bib56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ccr3.758","article-title":"Case report abscopal effect","volume":"5","author":"Sato","year":"2017","journal-title":"Clin. Case Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105613_bib57","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","article-title":"Fractionated radiation","volume":"83","author":"Schaue","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105613_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.20.02046","article-title":"Debunking abscopal effect","volume":"39","author":"Seiwert","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib59","first-page":"104","article-title":"Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy","volume":"12","author":"Shi","year":"2024","journal-title":"Biomark. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib60","first-page":"1229","article-title":"Host immune capability","volume":"63","author":"Stone","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(20)30391-X","article-title":"Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"9","author":"Theelen","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105613_bib62","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","article-title":"PEMBRO-RT trial","volume":"5","author":"Theelen","year":"2019","journal-title":"JAMA Oncol."},{"issue":"7547","key":"10.1016\/j.critrevonc.2026.105613_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation + checkpoint blockade","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105613_bib64","first-page":"640","article-title":"Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancer","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105613_bib65","article-title":"Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer","author":"Welsh","year":"2025","journal-title":"Nat. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105613_bib66","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/02841860600604611","article-title":"Regression of metastases","volume":"45","author":"Wers\u00e4ll","year":"2006","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib67","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/atm-23-1868","article-title":"Cryoablation abscopal effect","volume":"12","author":"Wetterwald","year":"2024","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105613_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/atm-23-1868","article-title":"Abscopal effect induced by cryoablation in a 55-year-old patient with metastatic dedifferentiated liposarcoma: a case report","volume":"12","author":"Wetterwald","year":"2024","journal-title":"Ann. Transl. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105613_bib69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fon-2018-0405","article-title":"JAVELIN Head and Neck 100: a Phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer","volume":"15","author":"Yu","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib70","article-title":"Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions","volume":"15","author":"Zeng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105613_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920937612","article-title":"Efficacy of PD-1\/PD-L1 blockade monotherapy in clinical trials","volume":"12","author":"Zhao","year":"2020","journal-title":"Ther. Adv. Med. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:02:21Z","timestamp":1793088141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":71,"alternative-id":["S1040842826005007"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105613","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The abscopal effect in cancer therapy: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105613"}}